StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences cash

Cash and short-term investments held at the end of each period.

NovaBridge Biosciences's cash was CN¥2.28B at Dec 31, 2023. For fiscal 2023 it was CN¥2.28B, down 33.8% from the year before. The highest annual figure on record is CN¥4.79B in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2023Dec 31, 2023CN¥2.28B-33.8%
FY2022Dec 31, 2022CN¥3.45B-19.3%
FY2021Dec 31, 2021CN¥4.28B-10.7%
FY2020Dec 31, 2020CN¥4.79B+291.0%
FY2019Dec 31, 2019CN¥1.23B-27.1%
FY2018Dec 31, 2018CN¥1.68B+307.3%
FY2017Dec 31, 2017CN¥412.71M+544.0%
FY2016Dec 31, 2016CN¥64.08M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023CN¥2.28B-47.5%
Q4 FY2022Dec 31, 2022CN¥3.45B-28.0%
Q2 FY2022Jun 30, 2022CN¥3.92B+31.2%
Q4 FY2021Dec 31, 2021CN¥4.28B+249.0%
Q2 FY2021Jun 30, 2021CN¥4.35B+239.6%
Q4 FY2020Dec 31, 2020CN¥4.79B+185.0%
Q3 FY2020Sep 30, 2020CN¥2.99B+624.1%
Q4 FY2019Dec 31, 2019CN¥1.23B+1812.1%
Q3 FY2019Sep 30, 2019CN¥1.28B–
Q4 FY2018Dec 31, 2018CN¥1.68B–
Q4 FY2017Dec 31, 2017CN¥412.71M–
Q4 FY2016Dec 31, 2016CN¥64.08M–

More NovaBridge Biosciences figures

See a number that looks wrong?